Earnings Alerts

Church & Dwight Co (CHD) Earnings: 2Q Net Sales Match Estimates at $1.51 Billion, Strong Cash Flow Outlook

“`html

  • Net Sales: Church & Dwight’s net sales reached $1.51 billion in the second quarter, matching estimates and marking a 3.9% year-over-year increase.
  • Consumer Domestic Sales: Organic sales in the Consumer Domestic segment grew by 3.8%, slightly exceeding the estimated 3.66% growth.
  • Specialty Products: Organic sales in Specialty Products increased by 3.9%, just below the estimated 4.06% growth.
  • Overall Organic Sales: Organic sales saw an overall increase of 4.7%.
  • Effective Tax Rate: The effective tax rate for the full year remains unchanged at approximately 23%.
  • Cash Flow Forecast: Full-year cash flow from operations is now expected to be approximately $1.08 billion, up from the previous forecast of $1.05 billion.
  • Organic Revenue Outlook: The full-year organic sales growth outlook has been revised to approximately 4%, down from the previous 4-5% forecast.
  • Gross Margin Expansion: The outlook for full-year adjusted gross margin expansion has been raised to approximately 100-110 basis points versus 2023, up from the previously expected 75 basis points.
  • Cash Flow Generation: Strong sales, margin expansion, and efficient working capital management resulted in robust cash flow generation in the first half, with over $1 billion of cash from operations expected for the full year.
  • Product Innovation: ARM & HAMMER has introduced a detergent sheet, POWER SHEETS, which is now available in select brick-and-mortar retailers following online success.
  • International Growth: The International Division saw organic growth of 9.3%, driven by growth in country subsidiaries and the Global Markets Group.
  • Domestic Consumption: Domestic consumption of products outpaced organic sales mainly due to retailer inventory reductions and prior year distribution gains for HERO.
  • Analyst Ratings: There are 11 buy, 11 hold, and 4 sell ratings for Church & Dwight.

“`


Church & Dwight Co on Smartkarma

Analysts on Smartkarma, such as Baptista Research, are closely following Church & Dwight Co and providing valuable insights. Baptista Research recently published a research report titled “Church & Dwight: Benefiting from Consumer Trade Down But Is It Enough? – Major Drivers.” The report highlights the company’s impressive third-quarter performance, where Church & Dwight Co exceeded revenue outlooks by 2.5% and organic revenue expectations by 0.8%. This consistent robust performance over the past four quarters has caught the attention of analysts, who are evaluating if the trend can be sustained.


A look at Church & Dwight Co Smart Scores

FactorScoreMagnitude
Value2
Dividend2
Growth3
Resilience3
Momentum3
OVERALL SMART SCORE2.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Church & Dwight Co., Inc., a diversified consumer products company known for brands like contraceptive products and vitamins, holds a mixed outlook based on Smartkarma Smart Scores. Despite receiving average scores for Value and Dividend at 2, the company shows promise in Growth, Resilience, and Momentum, with scores of 3 in each category. This indicates a positive long-term outlook for Church & Dwight Co., pointing towards potential growth and robustness amidst market fluctuations.

With a focus on expanding its product portfolio and maintaining steady performance, Church & Dwight Co. seems well-positioned to capitalize on growth opportunities and demonstrate resilience in changing market conditions. The company’s momentum further adds to its appeal, suggesting a proactive approach towards sustained success in the consumer products sector.

Summary of the company: Church & Dwight Co., Inc. is a diverse consumer products company that offers various personal products, catering to both consumer and industrial markets with an array of trusted brands in areas such as contraceptives, vitamins, pregnancy tests, and hair removers.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars